Published in Curr HIV/AIDS Rep on August 01, 2007
Macrophage-mediated dorsal root ganglion damage precedes altered nerve conduction in SIV-infected macaques. Am J Pathol (2011) 0.97
Initiating antiretrovirals during tuberculosis treatment: a drug safety review. Expert Opin Drug Saf (2011) 0.85
Unraveling the pathogenesis of HIV peripheral neuropathy: insights from a simian immunodeficiency virus macaque model. ILAR J (2014) 0.81
Over-reported peripheral neuropathy symptoms in a cohort of HIV infected and uninfected Rwandan women: the need for validated locally appropriate questionnaires. Afr Health Sci (2014) 0.79
Loss of corneal sensory nerve fibers in SIV-infected macaques: an alternate approach to investigate HIV-induced PNS damage. Am J Pathol (2014) 0.79
Insulin-like growth factor-1 prevents dorsal root ganglion neuronal tyrosine kinase receptor expression alterations induced by dideoxycytidine in vitro. Cell Mol Neurobiol (2013) 0.76
Urine methylmalonic acid levels in HIV-infected adults with peripheral neuropathy. Caspian J Intern Med (2013) 0.75
Prevalent neuropathy in a cohort of HIV-infected Kenyan sex workers using antiretroviral drugs. Pan Afr Med J (2016) 0.75
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol (2010) 7.56
Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol (2010) 5.03
Age and cigarette smoking are independently associated with the cutaneous vascular response to local warming. Microcirculation (2009) 2.05
Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain (2010) 1.84
Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera. J Infect Dis (2007) 1.79
Robust crop resistance to broadleaf and grass herbicides provided by aryloxyalkanoate dioxygenase transgenes. Proc Natl Acad Sci U S A (2010) 1.69
Clinical factors related to brain structure in HIV: the CHARTER study. J Neurovirol (2011) 1.57
Peripheral neuropathy in HIV: prevalence and risk factors. AIDS (2011) 1.53
Low atazanavir concentrations in cerebrospinal fluid. AIDS (2009) 1.45
Hypnosis for treatment of HIV neuropathic pain: a preliminary report. Pain Med (2013) 1.44
Regional patterns of brain metabolites in AIDS dementia complex. Neuroimage (2004) 1.40
AIDS and AIDS-treatment neuropathies. Curr Pain Headache Rep (2002) 1.39
Differential input by Ste5 scaffold and Msg5 phosphatase route a MAPK cascade to multiple outcomes. EMBO J (2004) 1.27
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. Toxicon (2013) 1.27
JC virus granule cell neuronopathy is associated with VP1 C terminus mutants. J Gen Virol (2011) 1.25
Efavirenz concentrations in CSF exceed IC50 for wild-type HIV. J Antimicrob Chemother (2010) 1.19
Neurocognitive impact of substance use in HIV infection. J Acquir Immune Defic Syndr (2011) 1.16
Autonomic dysfunction is common in HIV and associated with distal symmetric polyneuropathy. J Neurovirol (2013) 1.10
Sex-specific programming of cardiovascular physiology in children. Eur Heart J (2008) 1.10
Diagnosis and management of HIV-associated neuropathy. Neurol Clin (2008) 1.09
Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy. Ann Neurol (2008) 1.08
Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder. Clin Infect Dis (2013) 1.05
Antiepileptic drug selection for people with HIV/AIDS: evidence-based guidelines from the ILAE and AAN. Epilepsia (2012) 1.04
Size at birth and autonomic function during psychological stress. Hypertension (2007) 1.01
Neuromuscular diseases associated with HIV-1 infection. Muscle Nerve (2009) 0.99
Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome. Toxicon (2012) 0.98
A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy. J Acquir Immune Defic Syndr (2012) 0.97
A randomized trial evaluating Prosaptide for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain. PLoS One (2007) 0.97
Botulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled study. Arch Phys Med Rehabil (2009) 0.96
Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir. J Acquir Immune Defic Syndr (2012) 0.95
The roles of ethnicity and antiretrovirals in HIV-associated polyneuropathy: a pilot study. J Acquir Immune Defic Syndr (2009) 0.95
Role of metabolic syndrome components in HIV-associated sensory neuropathy. AIDS (2009) 0.95
Objective detection of evoked potentials using a bootstrap technique. Med Eng Phys (2006) 0.94
HIV-related neurocognitive impairment in the HAART era. Curr HIV/AIDS Rep (2009) 0.93
Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort. Arch Neurol (2008) 0.93
Localized feedback phosphorylation of Ste5p scaffold by associated MAPK cascade. J Biol Chem (2004) 0.92
Detection of impaired cerebral autoregulation improves by increasing arterial blood pressure variability. J Cereb Blood Flow Metab (2012) 0.91
Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection. J Neurovirol (2013) 0.91
Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration. J Antimicrob Chemother (2012) 0.90
Peripheral neuropathies associated with HIV and hepatitis C co-infection: a review. AIDS (2005) 0.90
Tolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic pain. J Pain Res (2011) 0.89
Health-related quality of life 'well-being' in HIV distal neuropathic pain is more strongly associated with depression severity than with pain intensity. Psychosomatics (2012) 0.89
Neuromuscular complications of human immunodeficiency virus infection. Phys Med Rehabil Clin N Am (2008) 0.88
NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials. AIDS Res Ther (2013) 0.86
A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy. J Neurovirol (2006) 0.86
Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat. J Neurovirol (2012) 0.85
Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER. J Neurovirol (2012) 0.85
Botulinum toxin for neuropathic pain and spasticity: an overview. Pain Manag (2014) 0.85
Anatomical localization of motor endplate bands in the human biceps brachii. J Clin Neuromuscul Dis (2007) 0.85
Virologic outcomes of HAART with concurrent use of cytochrome P450 enzyme-inducing antiepileptics: a retrospective case control study. AIDS Res Ther (2011) 0.85
Heart-rate and blood-pressure variability during psychophysiological tasks involving speech: influence of respiration. Psychophysiology (2007) 0.84
Therapeutic amprenavir concentrations in cerebrospinal fluid. Antimicrob Agents Chemother (2012) 0.84
Postural sway changes during pregnancy: a descriptive study using stabilometry. Eur J Obstet Gynecol Reprod Biol (2009) 0.84
Simplification of the research diagnosis of HIV-associated sensory neuropathy. HIV Clin Trials (2009) 0.84
Peripheral neuropathy in HIV infection. Handb Clin Neurol (2007) 0.84
Reliability and sensitivity of a wrist rig to measure motor control and spasticity in poststroke hemiplegia. Neurorehabil Neural Repair (2008) 0.83
Contralateral weakness following botulinum toxin for poststroke spasticity. Muscle Nerve (2012) 0.83
Understanding the etiology and management of HIV-associated peripheral neuropathy. Curr HIV/AIDS Rep (2014) 0.81
Cdc24 regulates nuclear shuttling and recruitment of the Ste5 scaffold to a heterotrimeric G protein in Saccharomyces cerevisiae. J Biol Chem (2005) 0.81
Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment. Virology (2012) 0.81
Pathways in the diagnosis and management of diabetic polyneuropathy. Curr Diab Rep (2015) 0.81
Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons. J Neuropsychiatry Clin Neurosci (2011) 0.81
Problematic prescription opioid use in an HIV-infected cohort: the importance of universal toxicology testing. J Acquir Immune Defic Syndr (2012) 0.81
HIV-associated distal neuropathic pain is associated with smaller total cerebral cortical gray matter. J Neurovirol (2014) 0.81
HIV neuropathy. Curr Opin HIV AIDS (2014) 0.80
Neuromuscular complications in HIV: effects of aging. J Neurovirol (2011) 0.80
The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIV. Am J Epidemiol (2014) 0.79
The relationship between upper limb activity and impairment in post-stroke hemiplegia. Disabil Rehabil (2009) 0.79
Effects of assisted and variable mechanical ventilation on cardiorespiratory interactions in anesthetized pigs. Physiol Meas (2012) 0.79
Low-frequency heart rate variability is related to the breath-to-breath variability in the respiratory pattern. Psychophysiology (2013) 0.78
A system identification analysis of neural adaptation dynamics and nonlinear responses in the local reflex control of locust hind limbs. J Comput Neurosci (2012) 0.78
Ste11p MEKK signals through HOG, mating, calcineurin and PKC pathways to regulate the FKS2 gene. BMC Mol Biol (2011) 0.78
Random perturbations of arterial blood pressure for the assessment of dynamic cerebral autoregulation. Physiol Meas (2012) 0.78
The dynamics of analogue signalling in local networks controlling limb movement. Eur J Neurosci (2012) 0.77
Understanding neuronal systems in movement control using Wiener/Volterra kernels: a dominant feature analysis. J Neurosci Methods (2011) 0.77
Gain and coherence estimates between respiration and heart-rate: differences between inspiration and expiration. Auton Neurosci (2013) 0.77
Tracking instantaneous pressure-to-flow dynamics of cerebral autoregulation induced by CO2 reactivity. Conf Proc IEEE Eng Med Biol Soc (2013) 0.77
Comparison of human expert and computer-automated systems using magnitude-squared coherence (MSC) and bootstrap distribution statistics for the interpretation of pattern electroretinograms (PERGs) in infants with optic nerve hypoplasia (ONH). Doc Ophthalmol (2015) 0.77
Safety profile of treatment in diabetic peripheral neuropathic pain. Pain Med (2007) 0.76
Challenges in developing novel therapies for peripheral neuropathies: a summary of The Foundation for Peripheral Neuropathy Scientific Symposium 2012. J Peripher Nerv Syst (2013) 0.76
Pilot study of intravenous immunoglobulin in HIV-associated myelopathy. AIDS Patient Care STDS (2009) 0.76
Lower CSF Aβ is Associated with HAND in HIV-Infected Adults with a Family History of Dementia. Curr HIV Res (2016) 0.76
Myopathy in HIV infection. Handb Clin Neurol (2007) 0.76
Spastic cocontraction in hemiparesis: effects of botulinum toxin. Muscle Nerve (2012) 0.76
Revisiting the frequency domain: the multiple and partial coherence of cerebral blood flow velocity in the assessment of dynamic cerebral autoregulation. Physiol Meas (2016) 0.76
Cutaneous vascular response to local warming: a response to letter from Cracowski and Roustit. Microcirculation (2010) 0.75
Optimizing measures of HIV-associated neuropathy. Muscle Nerve (2014) 0.75
Predictors of new-onset distal neuropathic pain in HIV-infected individuals in the era of combination antiretroviral therapy. Pain (2015) 0.75
Imaging findings of atypical mycobacterial infection in the temporal bone. Clin Imaging (2012) 0.75
Chronic pain disorders in HIV primary care: clinical characteristics and association with healthcare utilization. Pain (2016) 0.75
Assessing cerebral blood flow control from variability in blood pressure and arterial CO2 levels. Conf Proc IEEE Eng Med Biol Soc (2015) 0.75
Stress and cortisol in disaster evacuees: an exploratory study on associations with social protective factors. Appl Psychophysiol Biofeedback (2015) 0.75
Adaptive feedback analysis and control of programmable stimuli for assessment of cerebrovascular function. Med Biol Eng Comput (2013) 0.75
Poster 354 OnabotulinumtoxinA to Treat Common Postures in Post-Stroke Lower Limb Spasticity: Identification of a Treatment Paradigm. PM R (2016) 0.75